Biblio Discovery — Demo Discovery Service

11 results for "Jan, Muhammad Y"

Showing 1–11 · 1.03 seconds · RSS

  1. Journal Article Full text

    Optimization of Kidney Health in Liver Transplant Candidates: Pretransplant Considerations and Modalities

    Jan, Muhammad Y.; Patidar, Kavish R.; Ghabril, Marwan S. et al.

    Transplantation · 2024 · English · PubMed Central

    Patients with decompensated end-stage liver disease (ESLD) are at increased risk for mortality, and only liver transplantation (LT) offers meaningful hope for survival. These patients are at risk for kidney dysfunction through the continuum of care for ESLD including LT. We discuss the role of…

  2. Journal Article Full text

    Optimization and Protection of Kidney Health in Liver Transplant Recipients: Intra- and Postoperative Approaches

    Jan, Muhammad Y.; Patidar, Kavish R.; Ghabril, Marwan S. et al.

    Transplantation · 2024 · English · PubMed Central

    Postoperative acute kidney injury after liver transplant (LT) has long-term implications for kidney health. LT recipients are at risk of acute kidney injury due to a number of factors related to the donor liver, intraoperative factors including surgical technique, as well as recipient factors, such…

  3. Journal Article Full text

    Belatacept Maintenance Immunosuppression for Calcineurin Inhibitor Sparing or Avoidance in Pancreas Transplant Recipients With Progressive Renal or Renal Allograft Dysfunction

    Chen, Jeanne M.; Mangus, Richard S.; Sharfuddin, Asif A. et al.

    Clin Transplant · 2025 · English · PubMed Central

    Belatacept may be used to spare or replace calcineurin inhibitors (CNI) to preserve renal function. Use in pancreas transplant (PTx) is limited by increased risk of pancreas rejection. This retrospective analysis included all PTxs performed between 2004 and 2023. A 1:2 case/control analysis was…

  4. Journal Article Full text

    The Use of Long‐Term Monthly Basiliximab Infusions as Rescue Maintenance Immunosuppression in Pancreas Transplant Recipients

    Chen, Jeanne M.; Mangus, Richard S.; Sharfuddin, Asif A. et al.

    Clin Transplant · 2024 · English · PubMed Central

    This single‐center retrospective study was designed to evaluate the use of basiliximab as an alternative rescue maintenance immunosuppression in situations where standard maintenance immunosuppression is not tolerated after a pancreas transplant. All pancreas transplants performed between January…

  5. Journal Article Full text

    Nondirected Living Kidney Donation and Recipient Outcomes in the United States: A 20-Year Review

    Jan, Muhammad Y.; Yaqub, Muhammad S.; Adebiyi, Oluwafisayo O. et al.

    Kidney Int Rep · 2022 · English · PubMed Central

    INTRODUCTION: Nondirected donation (NDD) of the kidneys is a growing practice where donors who do not have any genetic or emotional relationship are selected to donate to a wide variety of recipients with a range of selection criteria and decisions which are left up to individual transplant…

  6. Journal Article Full text

    A National Survey of Practice Patterns for Accepting Living Kidney Donors With Prior COVID-19

    Jan, Muhammad Y.; Jawed, Areeba T.; Barros, Nicolas et al.

    Kidney Int Rep · 2021 · English · PubMed Central

    INTRODUCTION: A critical question facing transplant programs is whether, when, and how to safely accept living kidney donors (LKDs) who have recovered from COVID-19 infection. The purpose of the study is to understand current practices related to accepting these LKDs. METHODS: We surveyed US…

  7. Journal Article Full text

    Vasopressin for Post-kidney Transplant Hypotension

    Jan, Muhammad Y.; Moe, Sharon M.; Adebiyi, Oluwafisayo et al.

    Kidney Int Rep · 2022 · English · PubMed Central

    INTRODUCTION: Hypotension after deceased donor kidney transplant (DDKT) is a risk factor for delayed graft function (DGF) and poor graft survival (GS). We hypothesize that vasopressin use in hypotensive DDKT recipients (DDKTRs) to increase blood pressure (BP) reduces DGF rates and is safe without…

  8. Journal Article Full text

    Acute kidney injury in severe alcohol-associated hepatitis treated with anakinra plus zinc or prednisone

    Patidar, Kavish R.; Tu, Wanzhu; Cotter, Thomas G. et al.

    Hepatology · 2024 · English · PubMed Central

    BACKGROUND AND AIMS: In a recent trial, patients with severe alcohol-associated hepatitis treated with anakinra plus zinc (A+Z) had lower survival and higher acute kidney injury (AKI) rates versus prednisone (PRED). We characterize the clinical factors and potential mechanisms associated with AKI…